aceRNA Technologies
Developer of a novel drug designed to provide one class of gene-regulatory elements that control. The company specializes in regenerative medicine through the discovery of novel miRNA functions, enabl...
Valuation
$11.5M
Market implied
Share Price
N/A
Total Raised
$8.8M
Last Round
N/A